MedTrace Logo

Medical and Surgical Treatment of MRONJ (Medication-related Osteonecrosis of the Jaw Bones)

NCT06917846 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 102

Last updated 2025-04-09

No results posted yet for this study

Summary

MRONJ is an acronym used to describe medication-related osteonecrosis of the jaw bones. It has been reported by the AAOMS that bisphosphonates or denosumab can cause this condition. The management of medication-related osteonecrosis of the jaw (MRONJ) is challenging, and there is ongoing debate over whether medical or surgical treatment is the gold standard. The aim of this retrospective study is to investigate the efficacies of medical and surgical treatments of MRONJ and comparatively evaluate their outcomes.

Conditions

  • Osteonecrosis Due to Drugs, Jaw
  • Osteonecrosis of the Jaw, Bisphosphonate Related
  • Osteonecrosis of the Jaw, Bisphosphonate Induced

Sponsors & Collaborators

  • Akdeniz University

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-01-01
Primary Completion
2020-01-01
Completion
2023-01-01

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06917846 on ClinicalTrials.gov